Barclays’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.36M Sell
59,362
-67,089
-53% -$4.92M ﹤0.01% 1725
2025
Q1
$14.4M Sell
126,451
-42,076
-25% -$4.81M ﹤0.01% 848
2024
Q4
$8.49M Sell
168,527
-157,426
-48% -$7.93M ﹤0.01% 1228
2024
Q3
$15.1M Buy
325,953
+61,510
+23% +$2.85M ﹤0.01% 848
2024
Q2
$8.59M Sell
264,443
-10,801
-4% -$351K ﹤0.01% 960
2024
Q1
$6.93M Buy
275,244
+93,693
+52% +$2.36M ﹤0.01% 1210
2023
Q4
$5.9M Buy
181,551
+107,565
+145% +$3.49M ﹤0.01% 1376
2023
Q3
$2.02M Buy
73,986
+2,299
+3% +$62.6K ﹤0.01% 1668
2023
Q2
$1.6M Sell
71,687
-14,274
-17% -$318K ﹤0.01% 1883
2023
Q1
$1.86M Buy
85,961
+427
+0.5% +$9.25K ﹤0.01% 1697
2022
Q4
$1.74M Buy
85,534
+1,915
+2% +$38.9K ﹤0.01% 1726
2022
Q3
$2.15M Buy
83,619
+6,863
+9% +$176K ﹤0.01% 1610
2022
Q2
$1.83M Sell
76,756
-35,683
-32% -$848K ﹤0.01% 1643
2022
Q1
$2.53M Sell
112,439
-60,638
-35% -$1.36M ﹤0.01% 1600
2021
Q4
$3.43M Buy
173,077
+8,849
+5% +$175K ﹤0.01% 1470
2021
Q3
$3.23M Buy
164,228
+91,093
+125% +$1.79M ﹤0.01% 1528
2021
Q2
$1.61M Sell
73,135
-106,929
-59% -$2.35M ﹤0.01% 1848
2021
Q1
$4.28M Sell
180,064
-31,792
-15% -$756K ﹤0.01% 1302
2020
Q4
$5.54M Sell
211,856
-63,239
-23% -$1.65M ﹤0.01% 983
2020
Q3
$4.79M Buy
275,095
+14,058
+5% +$245K ﹤0.01% 995
2020
Q2
$4.39M Buy
261,037
+23,430
+10% +$394K ﹤0.01% 1003
2020
Q1
$2.83M Buy
237,607
+27,736
+13% +$330K ﹤0.01% 1149
2019
Q4
$2.54M Buy
209,871
+102,558
+96% +$1.24M ﹤0.01% 1722
2019
Q3
$1.52M Sell
107,313
-6,712
-6% -$94.9K ﹤0.01% 1980
2019
Q2
$1.27M Buy
114,025
+13,333
+13% +$149K ﹤0.01% 2164
2019
Q1
$1.18M Buy
100,692
+48,969
+95% +$575K ﹤0.01% 2024
2018
Q4
$691K Sell
51,723
-72,164
-58% -$964K ﹤0.01% 2062
2018
Q3
$1.74M Buy
123,887
+85,571
+223% +$1.2M ﹤0.01% 1883
2018
Q2
$602K Buy
38,316
+9,695
+34% +$152K ﹤0.01% 2163
2018
Q1
$470K Sell
28,621
-40,956
-59% -$673K ﹤0.01% 2328
2017
Q4
$1.26M Sell
69,577
-16,898
-20% -$305K ﹤0.01% 1511
2017
Q3
$1.67M Sell
86,475
-35,207
-29% -$680K ﹤0.01% 1318
2017
Q2
$1.44M Buy
121,682
+509
+0.4% +$6.01K ﹤0.01% 1374
2017
Q1
$1.33M Buy
121,173
+22,173
+22% +$243K ﹤0.01% 1410
2016
Q4
$719K Buy
99,000
+49,541
+100% +$360K ﹤0.01% 1664
2016
Q3
$322K Buy
49,459
+47,359
+2,255% +$308K ﹤0.01% 1928
2016
Q2
$11K Buy
+2,100
New +$11K ﹤0.01% 2958
2016
Q1
Sell
-5,000
Closed -$20K 3464
2015
Q4
$20K Buy
5,000
+4,677
+1,448% +$18.7K ﹤0.01% 2699
2015
Q3
$1K Sell
323
-3,692
-92% -$11.4K ﹤0.01% 3673
2015
Q2
$24K Sell
4,015
-3,483
-46% -$20.8K ﹤0.01% 2895
2015
Q1
$38K Sell
7,498
-2,041
-21% -$10.3K ﹤0.01% 2854
2014
Q4
$29K Buy
9,539
+3,454
+57% +$10.5K ﹤0.01% 3263
2014
Q3
$12K Buy
6,085
+587
+11% +$1.16K ﹤0.01% 3641
2014
Q2
$11K Sell
5,498
-113,506
-95% -$227K ﹤0.01% 3607
2014
Q1
$476K Buy
119,004
+117,822
+9,968% +$471K ﹤0.01% 2010
2013
Q4
$3K Sell
1,182
-812
-41% -$2.06K ﹤0.01% 4106
2013
Q3
$2K Sell
1,994
-762
-28% -$764 ﹤0.01% 3955
2013
Q2
$5K Buy
+2,756
New +$5K ﹤0.01% 4056